Columbia Seligman Premium Technology Growth Fund (STK)
Price:
40.45 USD
( - -0.15 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Athene Holding Ltd. 7.250% Fixe
VALUE SCORE:
8
2nd position
FS Credit Opportunities Corp.
VALUE SCORE:
13
The best
RiverNorth Opportunities Fund, Inc.
VALUE SCORE:
14
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Columbia Seligman Premium Technology Growth Fund is a closed ended equity mutual fund launched and managed by Columbia Management Investment Advisers, LLC. It invests in public equity markets. The fund seeks to invest in stocks of companies operating in the technology sector. It primarily invests in growth stocks of companies. It employs fundamental analysis with focus on factors like companies that have best growth prospects, trade at attractive valuations and deliver solid investment returns over time to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P North American Technology Sector Index. The fund was formerly known as Seligman Premium Technology Growth Fund, Inc. Columbia Seligman Premium Technology Growth Fund was formed on November 30, 2009 and is domiciled in the United States.
NEWS

Synthekine Announces Clinical Trial Collaboration with Merck to Evaluate STK-012 In Combination with Keytruda® (Pembrolizumab) and Chemotherapy in Ongoing Randomized Phase 2 Trial in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
businesswire.com
2026-02-26 08:00:00MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck (known as MSD outside of the United States and Canada). STK-012, a first-in-class α/β-IL-2 receptor biased partial agonist, will be evaluated in combination with standard of care chemotherapy and Keytruda® (pembrolizumab), Merck's anti-PD-1 (programmed cell death receptor-1) therapy, in the ongo.

Columbia Seligman Premium Technology Growth Fund (NYSE:STK) Shares Up 0.6% – Here’s Why
defenseworld.net
2026-02-12 05:18:50Columbia Seligman Premium Technology Growth Fund (NYSE: STK - Get Free Report) shares were up 0.6% on Wednesday. The stock traded as high as $41.06 and last traded at $40.65. Approximately 36,258 shares changed hands during mid-day trading, a decline of 31% from the average daily volume of 52,345 shares. The stock had previously closed

Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)
businesswire.com
2026-02-11 07:30:00BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today announced that the first patient has been dosed in the Phase 1 OSPREY study of STK-002, an investigational medicine for the treatment of Autosomal Dominant Optic Atrophy (ADOA). ADOA is a rare genetic disease that causes progressive and irreversible vision loss in both eyes starting in the first de.

Columbia Seligman Premium Technology Growth Fund Announces a First Quarter Distribution: 9.25% Annual Rate for IPO Investors
businesswire.com
2026-02-06 10:00:00BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a first-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The first-quarter distribution of $0.4625 per share is equal to a quarterly rate of 1.1577% (4.63% annualized) of the F.

STK: Tax-Efficient Income From The Growth Of AI
seekingalpha.com
2026-02-03 16:11:32Columbia Seligman Premium Technology Growth Fund remains a strong buy, trading at a rare 3.97% NAV discount despite robust 12-month total returns of 31.7%. STK offers a compelling 6.8% dividend yield, supported by dynamic covered call strategies and exposure to AI-driven technology leaders, including Bloom Energy. Option overlay strategies enhance income and buffer volatility, but heavy tech sector concentration exposes STK to downside if market sentiment shifts.

STK: A 5% Yield, Solid Long-Term Growth, And Deeper Discount
seekingalpha.com
2025-12-16 08:30:27Columbia Seligman Premium Technology Growth Fund (STK) offers long-term capital appreciation and moderate income via a tech-focused, buy-write strategy with dynamic overwrite exposure. STK has delivered a 15.82% annualized return since inception, outperforming the S&P 500, with a current -4.8% discount to NAV and a forward yield of 4.94%. The fund's rule-based overwrite approach allows for greater upside capture in bull markets, but exposes investors to significant drawdowns during volatility.

Columbia Seligman Premium Technology Growth Fund Announces a Fourth Quarter Distribution
businesswire.com
2025-11-07 12:07:00BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth quarter distribution, that is beyond its typical quarterly managed distribution, in the total amount of $1.3280 per share of common stock (which includes the Fund's typical quarterly $0.4625 per share distribution). A federal excise tax of 4% applies to funds that do not distribute substantially all of their annual income (including net gains) before the end of their f.

Contrasting Shutterstock (NYSE:SSTK) & DHI Group (NYSE:DHX)
defenseworld.net
2025-10-29 03:48:48Shutterstock (NYSE: SSTK - Get Free Report) and DHI Group (NYSE: DHX - Get Free Report) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability and earnings. Institutional and Insider Ownership 82.8% of

STK: 5% Yield, Historically Deep Discount
seekingalpha.com
2025-10-10 09:15:00Columbia Seligman Premium Technology Growth Fund is a core holding for us, delivering strong returns and high, growing distributions via tech stocks and covered calls. STK currently trades at a 4.47% discount to NAV, deeper than historical averages, but appears overbought on technical charts. The fund boasts veteran management, outperformance vs. peers and the S&P 500 over multiple timeframes, and a robust dividend history with special payouts.

10 Best CEFs This Month: Average Yield Of Nearly 9% (September 2025)
seekingalpha.com
2025-09-27 08:00:00For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight the ten best CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select 10 CEFs every month from around 500 closed-end funds.

What Moved Markets This Week
seekingalpha.com
2025-09-20 06:45:50Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

STK: The Most Attractive Valuation In A Decade (Rating Upgrade)
seekingalpha.com
2025-09-17 09:31:45Columbia Seligman Premium Technology Growth Fund is upgraded to a strong buy, trading at a rare 3.8% discount to NAV. STK offers exposure to top technology growth companies and utilizes a dynamic covered call strategy, delivering a 5.5% yield and impressive long-term returns. While STK lacks downside protection and underperforms tech ETFs in downturns, its income and capital appreciation track record remain strong.

10 Best CEFs This Month: Average Yield Of Nearly 9% (August 2025)
seekingalpha.com
2025-08-23 08:05:00For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight the ten best CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select 10 CEFs every month from around 500 closed-end funds.

Columbia Seligman Premium Technology Growth Fund Announces a Third Quarter Distribution: 9.25% Annual Rate for IPO Investors
businesswire.com
2025-08-08 10:00:00BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a third-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The third-quarter distribution of $0.4625 per share is equal to a quarterly rate of 1.4871% (5.95% annualized) of the F.

How To Collect Dividends Up To 11% From Tech Stocks
forbes.com
2025-08-03 10:30:03The Nasdaq has been rallying nonstop since April. Let's discuss three covered call fund payouts up to 11.2% that play the rally.

A 13% Dividends From AI? Here Are The Tickers
forbes.com
2025-07-31 17:30:03By now you've no doubt heard the argument that AI is a bubble, and there's no way Big Tech will make a significant profit from it, given the massive amounts of cash they've already piled in.

Synthekine Announces Clinical Trial Collaboration with Merck to Evaluate STK-012 In Combination with Keytruda® (Pembrolizumab) and Chemotherapy in Ongoing Randomized Phase 2 Trial in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
businesswire.com
2026-02-26 08:00:00MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck (known as MSD outside of the United States and Canada). STK-012, a first-in-class α/β-IL-2 receptor biased partial agonist, will be evaluated in combination with standard of care chemotherapy and Keytruda® (pembrolizumab), Merck's anti-PD-1 (programmed cell death receptor-1) therapy, in the ongo.

Columbia Seligman Premium Technology Growth Fund (NYSE:STK) Shares Up 0.6% – Here’s Why
defenseworld.net
2026-02-12 05:18:50Columbia Seligman Premium Technology Growth Fund (NYSE: STK - Get Free Report) shares were up 0.6% on Wednesday. The stock traded as high as $41.06 and last traded at $40.65. Approximately 36,258 shares changed hands during mid-day trading, a decline of 31% from the average daily volume of 52,345 shares. The stock had previously closed

Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)
businesswire.com
2026-02-11 07:30:00BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today announced that the first patient has been dosed in the Phase 1 OSPREY study of STK-002, an investigational medicine for the treatment of Autosomal Dominant Optic Atrophy (ADOA). ADOA is a rare genetic disease that causes progressive and irreversible vision loss in both eyes starting in the first de.

Columbia Seligman Premium Technology Growth Fund Announces a First Quarter Distribution: 9.25% Annual Rate for IPO Investors
businesswire.com
2026-02-06 10:00:00BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a first-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The first-quarter distribution of $0.4625 per share is equal to a quarterly rate of 1.1577% (4.63% annualized) of the F.

STK: Tax-Efficient Income From The Growth Of AI
seekingalpha.com
2026-02-03 16:11:32Columbia Seligman Premium Technology Growth Fund remains a strong buy, trading at a rare 3.97% NAV discount despite robust 12-month total returns of 31.7%. STK offers a compelling 6.8% dividend yield, supported by dynamic covered call strategies and exposure to AI-driven technology leaders, including Bloom Energy. Option overlay strategies enhance income and buffer volatility, but heavy tech sector concentration exposes STK to downside if market sentiment shifts.

STK: A 5% Yield, Solid Long-Term Growth, And Deeper Discount
seekingalpha.com
2025-12-16 08:30:27Columbia Seligman Premium Technology Growth Fund (STK) offers long-term capital appreciation and moderate income via a tech-focused, buy-write strategy with dynamic overwrite exposure. STK has delivered a 15.82% annualized return since inception, outperforming the S&P 500, with a current -4.8% discount to NAV and a forward yield of 4.94%. The fund's rule-based overwrite approach allows for greater upside capture in bull markets, but exposes investors to significant drawdowns during volatility.

Columbia Seligman Premium Technology Growth Fund Announces a Fourth Quarter Distribution
businesswire.com
2025-11-07 12:07:00BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth quarter distribution, that is beyond its typical quarterly managed distribution, in the total amount of $1.3280 per share of common stock (which includes the Fund's typical quarterly $0.4625 per share distribution). A federal excise tax of 4% applies to funds that do not distribute substantially all of their annual income (including net gains) before the end of their f.

Contrasting Shutterstock (NYSE:SSTK) & DHI Group (NYSE:DHX)
defenseworld.net
2025-10-29 03:48:48Shutterstock (NYSE: SSTK - Get Free Report) and DHI Group (NYSE: DHX - Get Free Report) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability and earnings. Institutional and Insider Ownership 82.8% of

STK: 5% Yield, Historically Deep Discount
seekingalpha.com
2025-10-10 09:15:00Columbia Seligman Premium Technology Growth Fund is a core holding for us, delivering strong returns and high, growing distributions via tech stocks and covered calls. STK currently trades at a 4.47% discount to NAV, deeper than historical averages, but appears overbought on technical charts. The fund boasts veteran management, outperformance vs. peers and the S&P 500 over multiple timeframes, and a robust dividend history with special payouts.

10 Best CEFs This Month: Average Yield Of Nearly 9% (September 2025)
seekingalpha.com
2025-09-27 08:00:00For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight the ten best CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select 10 CEFs every month from around 500 closed-end funds.

What Moved Markets This Week
seekingalpha.com
2025-09-20 06:45:50Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

STK: The Most Attractive Valuation In A Decade (Rating Upgrade)
seekingalpha.com
2025-09-17 09:31:45Columbia Seligman Premium Technology Growth Fund is upgraded to a strong buy, trading at a rare 3.8% discount to NAV. STK offers exposure to top technology growth companies and utilizes a dynamic covered call strategy, delivering a 5.5% yield and impressive long-term returns. While STK lacks downside protection and underperforms tech ETFs in downturns, its income and capital appreciation track record remain strong.

10 Best CEFs This Month: Average Yield Of Nearly 9% (August 2025)
seekingalpha.com
2025-08-23 08:05:00For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight the ten best CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select 10 CEFs every month from around 500 closed-end funds.

Columbia Seligman Premium Technology Growth Fund Announces a Third Quarter Distribution: 9.25% Annual Rate for IPO Investors
businesswire.com
2025-08-08 10:00:00BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a third-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The third-quarter distribution of $0.4625 per share is equal to a quarterly rate of 1.4871% (5.95% annualized) of the F.

How To Collect Dividends Up To 11% From Tech Stocks
forbes.com
2025-08-03 10:30:03The Nasdaq has been rallying nonstop since April. Let's discuss three covered call fund payouts up to 11.2% that play the rally.

A 13% Dividends From AI? Here Are The Tickers
forbes.com
2025-07-31 17:30:03By now you've no doubt heard the argument that AI is a bubble, and there's no way Big Tech will make a significant profit from it, given the massive amounts of cash they've already piled in.




